KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Current Taxes (2022 - 2024)

Historic Current Taxes for Acadia Pharmaceuticals (ACAD) over the last 3 years, with Q2 2024 value amounting to $8.5 million.

  • Acadia Pharmaceuticals' Current Taxes changed N/A to $8.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $8.5 million, marking a year-over-year change of. This contributed to the annual value of $8.7 million for FY2023, which is 221034.48% up from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Current Taxes of $8.5 million as of Q2 2024.
  • Acadia Pharmaceuticals' 5-year Current Taxes high stood at $8.7 million for Q4 2023, and its period low was $377000.0 during Q4 2022.
  • For the 3-year period, Acadia Pharmaceuticals' Current Taxes averaged around $6.7 million, with its median value being $8.5 million (2023).
  • The largest annual percentage gain for Acadia Pharmaceuticals' Current Taxes in the last 5 years was 221034.48% (2023), contrasted with its biggest fall of 221034.48% (2023).
  • Over the past 3 years, Acadia Pharmaceuticals' Current Taxes (Quarter) stood at $377000.0 in 2022, then soared by 2210.34% to $8.7 million in 2023, then dropped by 2.92% to $8.5 million in 2024.
  • Its Current Taxes stands at $8.5 million for Q2 2024, versus $7.6 million for Q1 2024 and $8.7 million for Q4 2023.